Aldoketoreductase family 1B10 (AKR1B10) as a biomarker to distinguish hepatocellular carcinoma from benign liver lesions

Human Pathology

Volumn 45, Issue 4, 2014, Pages 834-843

  Matkowskyj, Kristina A ^a,b   Bai, Han ^a,c   Liao, Jie ^a   Zhang, Wanying ^a   Li, Haonan ^a   Rao, Sambasiva ^a   Omary, Reed ^d   Yang, Guang Yu ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c CHINA MEDICAL UNIVERSITY   (China)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AKR1B10; Focal nodular hyperplasia; Hepatic adenoma; Hepatocellular carcinoma

Indexed keywords

ALDOKETOREDUCTASE 1B10; DOXORUBICIN; OXIDOREDUCTASE; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CARCINOGENESIS; CARCINOMA CELL; CELL PROLIFERATION; CELL SIZE; CHEMOSENSITIVITY; COLONY FORMATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER FOCAL NODULAR HYPERPLASIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PROTEIN EXPRESSION; TREATMENT RESPONSE;

AKR1B10; FOCAL NODULAR HYPERPLASIA; HEPATIC ADENOMA; HEPATOCELLULAR CARCINOMA;

ADULT; AGED; ALDEHYDE REDUCTASE; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER DISEASES; LIVER NEOPLASMS; MALE; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL;

EID: 84896531295     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2013.12.002     Document Type: Article

References (35)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 61 2011 69 90
2. S.F. Altekruse, K.A. McGlynn, and M.E. Reichman Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005 J Clin Oncol 27 2009 1485 1491
3. R. Wong, and D.A. Corley Racial and ethnic variations in hepatocellular carcinoma incidence within the United States Am J Med 121 2008 525 531 (Pubitemid 351694349)
4. J.F. Perz, G.L. Armstrong, L.A. Farrington, Y.J. Hutin, and B.P. Bell The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide J Hepatol 45 2006 529 538 (Pubitemid 44307383)
5. M.S. Ascha, I.A. Hanouneh, R. Lopez, T.A. Tamimi, A.F. Feldstein, and N.N. Zein The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis Hepatology 51 2010 1972 1978
6. R. Lencioni, D. Cioni, and L. Crocetti et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation Radiology 234 2005 961 967 (Pubitemid 40250844)
7. L. Marelli, R. Stigliano, and C. Triantos et al. Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies Cardiovasc Intervent Radiol 30 2007 6 25 (Pubitemid 44900485)
8. D.M. Choi, H.K. Lim, and H. Rhim et al. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series Eur Radiol 17 2007 684 692
9. P. Sharma, V. Balan, and J.L. Hernandez et al. Liver transplantation for hepatocellular carcinoma: the MELD impact Liver Transpl 10 2004 36 41 (Pubitemid 38885890)
10. H. Nathan, R.D. Schulick, M.A. Choti, and T.M. Pawlik Predictors of survival after resection of early hepatocellular carcinoma Ann Surg 249 2009 799 805
11. R. Teramoto, H. Minagawa, and M. Honda et al. Protein expression profile characteristic to hepatocellular carcinoma revealed by 2D-DIGE with supervised learning Biochim Biophys Acta 1784 2008 764 772
12. S. Heringlake, M. Hofdmann, A. Fiebeler, M.P. Manns, W. Schmiegel, and A. Tannapfel Identification and expression analysis of the aldo-ketoreductase1-B10 gene in primary malignant liver tumours J Hepatol 52 2010 220 227
13. R. Satow, M. Shitashige, and Y. Kanai et al. Combined functional genome survey of therapeutic targets for hepatocellular carcinoma Clin Cancer Res 16 2010 2518 2528
14. D. Cao, S.T. Fan, and S.S. Chung Identification and characterization of a novel human aldose reductase-like gene J Biol Chem 273 1998 11429 11435 (Pubitemid 28272034)
15. T.M. Penning AKR1B10: a new diagnostic marker of non-small cell lung carcinoma in smokers Clin Cancer Res 11 2005 1687 1690 (Pubitemid 40476161)
16. J. Breton, M.C. Gage, and A.W. Hay et al. Proteomic screening of a cell line model of esophageal carcinogenesis identifies cathepsin D and aldo-keto reductase 1C2 and 1B10 dysregulation in Barrett's esophagus and esophageal adenocarcinoma J Proteome Res 7 2008 1953 1962
17. H. Yoshitake, M. Takahashi, and H. Ishikawa et al. Aldo-keto reductase family 1, member B10 in uterine carcinomas: a potential risk factor of recurrence after surgical therapy in cervical cancer Int J Gynecol Cancer 17 2007 1300 1306 (Pubitemid 350077355)
18. Y.T. Chung, K. Matkowskyj, and H. Li et al. Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma Mod Pathol 25 2012 758 766
19. O. Gallego, F.X. Ruiz, and A. Ardevol et al. Structural basis for the high all-trans-retinaldehyde reductase activity of the tumor marker AKR1B10 Proc Natl Acad Sci U S A 104 2007 20764 20769
20. S. Endo, T. Matsunaga, and H. Mamiya et al. Kinetic studies of AKR1B10, human aldose reductase-like protein: endogenous substrates and inhibition by steroids Arch Biochem Biophys 487 2009 1 9
21. G.K. Balendiran Fibrates in the chemical action of daunorubicin Curr Cancer Drug Targets 9 2009 366 369
22. L.S.H. Zhong, C. Huang, H. Jing, and D. Cao AKR1B10 induces cell resistance to daunorubicin and idarubicin by reducing C13 ketonic group Toxicol Appl Pharmacol 255 2011 40 47
23. T. Matsunaga, Y. Wada, S. Endo, M. Soda, O. El-Kabbani, and A. Hara Aldo-keto reductase 1B10 and its role in proliferation capacity of drug-resistant cancers Front Pharmacol 3 2012 1 11
24. X.D. Yang, D.N. Tang, J. Wang, and D.L. Cao Screening of the drug resistance-associated gene in HepG2 cell line transfected with aldose reductase like gene-1 (ARL-1) Ai Zheng 22 2003 1289 1295
25. H.J. Martin, U. Breyer-Pfaff, V. Wsol, S. Venz, S. Block, and E. Maser Purification and characterization of AKR1B10 from human liver: role in carbonyl reduction of xenobiotics Drug Metab Dispos 34 2006 464 470 (Pubitemid 43290905)
26. F.X. Ruiz, O. Gallego, and A. Ardevol et al. Aldo-keto reductases from the AKR1B subfamily: retinoid specificity and control of cellular retinoic acid levels Chem Biol Interact 178 2009 171 177
27. J. Gao, J. Liao, and G.Y. Yang CAAX-box protein, prenylation process and carcinogenesis Am J Transl Res 1 2009 312 325
28. W. Wei, H.J. Liang, and J.F. Cui et al. Effects of AKR1B10 gene silence on the growth and gene expression of HCC cell line MHCC97H Zhonghua Gan Zang Bing Za Zhi 18 2010 666 671
29. K.J. Schmitz, G.C. Sotiropoulos, and H.A. Baba et al. AKR1B10 expression is associated with less aggressive hepatocellular carcinoma: a clinicopathological study of 168 cases Liver Int 31 2011 810 816
30. J. Bruix, and M. Sherman American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update Hepatology 53 2011 1020 1022
31. W.M. Coston, S. Loera, and S.K. Lau et al. Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry Am J Surg Pathol 32 2008 433 444 (Pubitemid 351398936)
32. N. Shafizadeh, L.D. Ferrell, and S. Kakar Utility and limitations of glypican-3 expression for the diagnosis of hepatocellular carcinoma at both ends of the differentiation spectrum Mod Pathol 21 2008 1011 1018
33. J. Zucman-Rossi, E. Jeannot, and J.T. Nhieu et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC Hepatology 43 2006 515 524
34. Y.J. Chen, C.C. Yuan, and K.C. Chow et al. Overexpression of dihydrodiol dehydrogenase is associated with cisplatin-based chemotherapy resistance in ovarian cancer patients Gynecol Oncol 97 2005 110 117
35. M. Ueda, Y.C. Hung, and J.T. Chen et al. Infection of human papillomavirus and overexpression of dihydrodiol dehydrogenase in uterine cervical cancer Gynecol Oncol 102 2006 173 181 (Pubitemid 44041634)